These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17666645)

  • 1. Trastuzumab use for metastatic breast cancer in pregnancy.
    Sekar R; Stone PR
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):507-10. PubMed ID: 17666645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios.
    Watson WJ
    Obstet Gynecol; 2005 Mar; 105(3):642-3. PubMed ID: 15738038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of breast cancer with trastuzumab during pregnancy.
    Pant S; Landon MB; Blumenfeld M; Farrar W; Shapiro CL
    J Clin Oncol; 2008 Mar; 26(9):1567-9. PubMed ID: 18349415
    [No Abstract]   [Full Text] [Related]  

  • 4. Herceptin (trastuzumab) therapy in a twin pregnancy with associated oligohydramnios.
    Beale JM; Tuohy J; McDowell SJ
    Am J Obstet Gynecol; 2009 Jul; 201(1):e13-4. PubMed ID: 19398090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy.
    Fanale MA; Uyei AR; Theriault RL; Adam K; Thompson RA
    Clin Breast Cancer; 2005 Oct; 6(4):354-6. PubMed ID: 16277887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy.
    Bader AA; Schlembach D; Tamussino KF; Pristauz G; Petru E
    Lancet Oncol; 2007 Jan; 8(1):79-81. PubMed ID: 17196514
    [No Abstract]   [Full Text] [Related]  

  • 7. A case study of trastuzumab treatment for metastatic breast cancer in pregnancy: fetal risks and management of cerebral metastases.
    Mandrawa CL; Stewart J; Fabinyi GC; Walker SP
    Aust N Z J Obstet Gynaecol; 2011 Aug; 51(4):372-6. PubMed ID: 21806575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of pertuzumab and trastuzumab during pregnancy.
    Yildirim N; Bahceci A
    Anticancer Drugs; 2018 Sep; 29(8):810-813. PubMed ID: 30110018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bi-weekly nab-paclitaxel and trastuzumab therapy effective against recurrent breast cancer with multiple lung metastases in elderly patient who had previously undergone two chemotherapeutic regimens for treatment of metastatic disease-a case Report].
    Sakurai T; Jinta E; Suzuma T; Yoshimura G; Umemura T; Sakurai T
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1703-6. PubMed ID: 23152023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A long survival of a patient with poor performance status who suffered from advanced right breast cancer with multiple lung metastases controlled by trastuzumab as a key drug].
    Fujikawa T; Mukai K; Tanaka A; Abe T; Yoshimoto Y; Tada S; Maekawa H; Shimoike N; Tanaka H; Kawashima T; Yokota T
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):1009-12. PubMed ID: 22705704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trastuzumab in pregnancy associated with poor fetal outcome.
    Witzel ID; Müller V; Harps E; Janicke F; Dewit M
    Ann Oncol; 2008 Jan; 19(1):191-2. PubMed ID: 18084047
    [No Abstract]   [Full Text] [Related]  

  • 12. Herceptin therapy in pregnancy: continuation of pregnancy in the presence of anhydramnios.
    Warraich Q; Smith N
    J Obstet Gynaecol; 2009 Feb; 29(2):147-8. PubMed ID: 19274553
    [No Abstract]   [Full Text] [Related]  

  • 13. Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review.
    Shrim A; Garcia-Bournissen F; Maxwell C; Farine D; Koren G
    Reprod Toxicol; 2007 Jun; 23(4):611-3. PubMed ID: 17399946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature.
    Potluri V; Lewis D; Burton GV
    Clin Breast Cancer; 2006 Jun; 7(2):167-70. PubMed ID: 16800979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lapatinib plus capecitabine resolved human epidermal growth factor receptor 2-positive brain metastases.
    Glück S; Castrellon A
    Am J Ther; 2009; 16(6):585-90. PubMed ID: 19287304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of trastuzumab without chemotherapy as a post-operative adjuvant therapy in HER2-positive elderly breast cancer patients: randomized controlled trial [RESPECT (N-SAS BC07)].
    Sawaki M; Tokudome N; Mizuno T; Nakayama T; Taira N; Bando H; Murakami S; Yamamoto Y; Kashiwaba M; Iwata H; Uemura Y; Ohashi Y
    Jpn J Clin Oncol; 2011 May; 41(5):709-12. PubMed ID: 21355003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study.
    Untch M; Rezai M; Loibl S; Fasching PA; Huober J; Tesch H; Bauerfeind I; Hilfrich J; Eidtmann H; Gerber B; Hanusch C; Kühn T; du Bois A; Blohmer JU; Thomssen C; Dan Costa S; Jackisch C; Kaufmann M; Mehta K; von Minckwitz G
    J Clin Oncol; 2010 Apr; 28(12):2024-31. PubMed ID: 20308670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer.
    Baselga J; Perez EA; Pienkowski T; Bell R
    Oncologist; 2006; 11 Suppl 1():4-12. PubMed ID: 16971734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial.
    Joensuu H; Bono P; Kataja V; Alanko T; Kokko R; Asola R; Utriainen T; Turpeenniemi-Hujanen T; Jyrkkiö S; Möykkynen K; Helle L; Ingalsuo S; Pajunen M; Huusko M; Salminen T; Auvinen P; Leinonen H; Leinonen M; Isola J; Kellokumpu-Lehtinen PL
    J Clin Oncol; 2009 Dec; 27(34):5685-92. PubMed ID: 19884557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
    Marty M; Cognetti F; Maraninchi D; Snyder R; Mauriac L; Tubiana-Hulin M; Chan S; Grimes D; Antón A; Lluch A; Kennedy J; O'Byrne K; Conte P; Green M; Ward C; Mayne K; Extra JM
    J Clin Oncol; 2005 Jul; 23(19):4265-74. PubMed ID: 15911866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.